Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

TRACON Pharma Q1 EPS $(1.33) Misses $(1.19) Estimate, Sales $100.00K

Author: Benzinga Newsdesk | May 14, 2024 04:06pm
TRACON Pharma (NASDAQ:TCON) reported quarterly losses of $(1.33) per share which missed the analyst consensus estimate of $(1.19) by 11.76 percent. This is a 269.44 percent decrease over losses of $(0.36) per share from the same period last year. The company reported $100.00 thousand in sales this quarter.

Posted In: TCON